ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
Recruiting · NCT03685045 · Registry updated 2026-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not applicable | 2026-05-14 | NCT03685045 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kirby Institute | 19 |
| National Health and Medical Research Council, Australia | 27 |
32 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.